Aniplus Inc. (KOSDAQ:310200)
1,925.00
+6.00 (0.31%)
At close: Sep 28, 2026
Aniplus Revenue
Aniplus had revenue of 32.31B KRW in the quarter ending June 30, 2026, with 12.91% growth. This brings the company's revenue in the last twelve months to 154.24B, up 19.65% year-over-year. In the year 2025, Aniplus had annual revenue of 150.30B with 14.75% growth.
Revenue (ttm)
154.24B
Revenue Growth
+19.65%
P/S Ratio
0.65
Revenue / Employee
2.86B
Employees
54
Market Cap
100.81B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 150.30B | 19.32B | 14.75% |
| Dec 31, 2024 | 130.98B | 19.63B | 17.63% |
| Dec 31, 2023 | 111.35B | 53.53B | 92.59% |
| Dec 31, 2022 | 57.82B | 8.78B | 17.90% |
| Dec 31, 2021 | 49.04B | 33.15B | 208.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wonik Pne | 239.67B |
| NAMU AX | 139.65B |
| Amogreentech Co.,Ltd | 126.96B |
| Gridwiz | 118.82B |
| SM Culture & Contents | 110.37B |
| ALUX Co., Ltd. | 76.26B |
| Kangdong C&L | 73.19B |
| Cell Biotech | 60.40B |